CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market sale Director sold 6,105 shares at $4.28 ($26,117)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.33 ($21,640)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.40 ($22,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $4.22 ($84,400)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
Page 50 of 76 · 1,519 filings